Dr. Kanuparthy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5209 Craigs Creek Drive
Louisville, KY 40241
Education & Training
University of Louisville School of MedicineClass of 2021
Certifications & Licensure
MA State Medical License 2024 - 2025
RI State Medical License 2021 - 2025
Publications & Presentations
PubMed
- Effects of diet-induced metabolic syndrome on cardiac function and angiogenesis in response to the sodium-glucose cotransporter-2 inhibitor canagliflozin.Dwight D Harris, Mark Broadwin, Sharif A Sabe, Chris Stone, Meghamsh Kanuparthy
The Journal of Thoracic and Cardiovascular Surgery. 2024-11-01 - Proteomic Profiling of SGLT-2 Inhibitor Canagliflozin in a Swine Model of Chronic Myocardial Ischemia.Dwight D Harris, Sharif A Sabe, Mark Broadwin, Christopher Stone, Cynthia Xu
Biomedicines. 2024-03-06 - 2 citationsCrafting a Rigorous, Clinically Relevant Large Animal Model of Chronic Myocardial Ischemia: What Have We Learned in 20 Years?Christopher R Stone, Dwight D Harris, Mark Broadwin, Meghamsh Kanuparthy, Sharif A Sabe
Methods and Protocols. 2024-02-19
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
